Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

Inari has been the stronger player in PE, with better than 70% share. Importantly, the VTE market remains significantly underpenetrated, with only about 15% to 20% adoption in the U.S. and lower ...

NARI, with a market capitalization of $2.99 billion, is a commercial-stage medical device ... to Inari Medical’s estimate, there are 1.9 million people with VTE in the United States each year, with 1 ...

Why the splash? Inari's game-changing clot-removal devices for deep vein thrombosis (DVT) and pulmonary embolism (PE) are a perfect fit for Stryker's neurovascular empire. This move doesn't just pad ...

Insights into the digital tools that can help improve patient engagement and advance understanding in deep vein thrombosis ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion.

Stryker will acquire Inari in an all-cash deal for $80 per share, valuing it at roughly $4.9 billion. The deal for the vascular medical device maker was first reported by Reuters Monday afternoon ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth US$4.9 billion. The deal for Inari ...

In this article, we are going to take a look at where Inari Medical ... to $79.4 on January 16. The medical device company has treated more than 100,000 patients so far and offers a diverse ...